Presentation TCT 2012 Contrast-Induced Acute Kidney Injury: Have We Reached a Ceiling in Prevention? Presenter: Roxana Mehran October 26, 2012 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2012 Up Next Presentation TCT 2012 Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter? Presenter: C. Michael Gibson October 25, 2012 More slides + Presentation TCT 2012 PC Trial: Additional Findings Presenter: Stephan Windecker October 26, 2012 Presentation TCT 2012 "Short- Versus Long-term Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Randomized Multicentre Trial." Circulation. 2012;125:2015-2026. Presenter: Marco Valgimigli October 24, 2012 We Recommend
Presentation TCT 2012 Should Rivaroxaban Be Used in STEMI Patients, and Does Choice of ADP Antagonist (with Rivaroxaban) Matter? Presenter: C. Michael Gibson October 25, 2012
Presentation TCT 2012 "Short- Versus Long-term Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Randomized Multicentre Trial." Circulation. 2012;125:2015-2026. Presenter: Marco Valgimigli October 24, 2012